Paper37541802
Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma.
Pfisterer N and 5 others. Pancreatology, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma. Papers, record 37541802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37541802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pancreatic Neoplasms | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Microbiota | Major topic |
| Humans | |
| Mice | |
| Animals | |
| In Situ Hybridization, Fluorescence | |
| RNA, Ribosomal, 16S | |
| Disease Models, Animal |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42404769 | Intratumoral microbiome: a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42404769 | PubMed |
| 42098751 | Intratumoral microbiota promote pancreatic cancer progression via NaAc-mediated activation of the GPR43/AMPK/HADH pathway. | J Transl Med | 2026 | https://conductscience.org/library/papers/42098751 | PubMed |
| 40427173 | From Genes to Environment: Elucidating Pancreatic Carcinogenesis Through Genetically Engineered and Risk Factor-Integrated Mouse Models. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40427173 | PubMed |
| 40247312 | Intratumoral microbiota for hepatocellular carcinoma: from preclinical mechanisms to clinical cancer treatment. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40247312 | PubMed |
| 40243134 | Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients. | United European Gastroenterol J | 2025 | https://conductscience.org/library/papers/40243134 | PubMed |
| 40136500 | Decoding the Tumor-Associated Microbiota: From Origins to Nanomedicine Applications in Cancer Therapy. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40136500 | PubMed |
| 40072088 | Inflammatory Stimuli and Fecal Microbiota Transplantation Accelerate Pancreatic Carcinogenesis in Transgenic Mice, Accompanied by Changes in the Microbiota Composition. | Cells | 2025 | https://conductscience.org/library/papers/40072088 | PubMed |
| 39199305 | Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199305 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37541802
GET https://conductscience.org/api/papers/v1/37541802/authors